|
G |
ABCC4 |
ATP binding cassette subfamily C member 4 |
multiple interactions |
EXP |
Mefloquine inhibits the reaction [ABCC4 protein affects the export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; verlukast inhibits the reaction [ABCC4 protein affects the export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein] |
CTD |
PMID:16004972 |
|
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
|
|
G |
ABCC5 |
ATP binding cassette subfamily C member 5 |
increases export multiple interactions |
EXP |
ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein daidzein inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; hesperetin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; naringenin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; Quercetin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; resveratrol inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; Silymarin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; verlukast inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein] |
CTD |
PMID:16156793 |
|
NCBI chr 3:183,919,934...184,017,884
Ensembl chr 3:183,919,934...184,017,939
|
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
affects transport multiple interactions increases export increases transport |
ISO EXP |
ABCC2 protein affects the transport of 5(6)-carboxy-2',7'-dichlorofluorescein 4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein; Ascorbic Acid inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]]; Ascorbic Acid promotes the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Atorvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Benzbromarone inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Calcium deficiency inhibits the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; cyanoginosin LR inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Cyclosporine inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Fluvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Lovastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; microcystin RR inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; microcystin-LF inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; pitavastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Pravastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Probenecid inhibits the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein analog]; Rosuvastatin Calcium analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Simvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Tobacco Smoke Pollution inhibits the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein analog] ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein; ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein analog [ABCC2 gene mutant form results in increased expression of ABCC3 protein] which results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein; ABCC2 gene mutant form inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein; Atorvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Fluvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Fluvastatin promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; Lovastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; pitavastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Pravastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Pravastatin promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; Rosuvastatin Calcium analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Rosuvastatin Calcium promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; Simvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein] |
CTD |
PMID:19326901 PMID:21240898 PMID:21341280 PMID:23562342 PMID:24907646 PMID:24909372 PMID:24973091 PMID:25862123 PMID:27450509 PMID:31348918 More...
|
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ABCC3 |
ATP binding cassette subfamily C member 3 |
multiple interactions increases transport |
ISO EXP |
[ABCC2 gene mutant form results in increased expression of ABCC3 protein] which results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein Benzbromarone inhibits the reaction [ABCC3 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein] |
CTD |
PMID:24907646 PMID:31348918 |
|
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
|
|
G |
ABCC5 |
ATP binding cassette subfamily C member 5 |
multiple interactions increases transport |
EXP |
Benzbromarone inhibits the reaction [ABCC5 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein] |
CTD |
PMID:31348918 |
|
NCBI chr 3:183,919,934...184,017,884
Ensembl chr 3:183,919,934...184,017,939
|
|
|
G |
SLC22A8 |
solute carrier family 22 member 8 |
multiple interactions increases transport |
EXP |
quercetin 3'-sulfate inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein]; quercetin 3-O-glucuronide analog inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein]; quercetin 3-O-glucuronide inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein] |
CTD |
PMID:21244849 |
|
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
|
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
EXP |
ABCC2 protein affects the transport of [5-chloromethylfluorescein co-treated with Glutathione] |
CTD |
PMID:16049127 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 |
increases export |
EXP |
ABCC1 protein results in increased export of 6-carboxyfluorescein |
CTD |
PMID:17940500 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
affects export multiple interactions |
EXP |
ABCC2 protein affects the export of 6-carboxyfluorescein Probenecid inhibits the reaction [ABCC2 protein affects the export of 6-carboxyfluorescein] |
CTD |
PMID:11477083 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
SLC22A11 |
solute carrier family 22 member 11 |
multiple interactions increases uptake increases import |
EXP |
glutaric acid promotes the reaction [SLC22A11 protein results in increased import of 6-carboxyfluorescein]; p-Aminohippuric Acid promotes the reaction [SLC22A11 protein results in increased import of 6-carboxyfluorescein]; Probenecid inhibits the reaction [SLC22A11 protein results in increased import of 6-carboxyfluorescein]; Probenecid inhibits the reaction [SLC22A11 protein results in increased uptake of 6-carboxyfluorescein]; Sulpiride inhibits the reaction [SLC22A11 protein results in increased uptake of 6-carboxyfluorescein] |
CTD |
PMID:20639259 PMID:28597291 |
|
NCBI chr11:64,555,941...64,572,875
Ensembl chr11:64,555,690...64,572,875
|
|
G |
SLC22A6 |
solute carrier family 22 member 6 |
multiple interactions increases import |
EXP |
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A6 protein results in increased import of 6-carboxyfluorescein]; glutaric acid promotes the reaction [SLC22A6 protein results in increased import of 6-carboxyfluorescein]; Probenecid inhibits the reaction [SLC22A6 protein results in increased import of 6-carboxyfluorescein] |
CTD |
PMID:28629854 |
|
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
|
|
G |
SLC22A8 |
solute carrier family 22 member 8 |
increases import multiple interactions |
EXP |
SLC22A8 protein results in increased import of 6-carboxyfluorescein 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine promotes the reaction [2-amino-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]]; 2-amino-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; 2-amino-9H-pyrido(2,3-b)indole promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]]; 3-amino-1-methyl-5H-pyrido(4,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; Cadmium Chloride promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; glutaric acid promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; lead chloride promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; Probenecid inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; sodium arsenate promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein] |
CTD |
PMID:28629854 |
|
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
|
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
affects localization |
EXP |
mangostin affects the localization of AIFM1 protein |
CTD |
PMID:24480042 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
EXP |
mangostin results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:23954321 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP |
mangostin results in increased expression of BAX protein mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA] |
CTD |
PMID:24480042 PMID:26357513 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression multiple interactions |
EXP |
mangostin results in decreased expression of BCL2 protein mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA] |
CTD |
PMID:24480042 PMID:26357513 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BID |
BH3 interacting domain death agonist |
decreases expression |
EXP |
mangostin results in decreased expression of BID protein |
CTD |
PMID:24480042 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
EXP |
mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP3 protein] |
CTD |
PMID:26357513 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
|
|
G |
CASP7 |
caspase 7 |
multiple interactions increases activity |
EXP |
ESR1 protein affects the reaction [mangostin results in increased activity of CASP7 protein] |
CTD |
PMID:24480042 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP8 |
caspase 8 |
increases activity |
EXP |
mangostin results in increased activity of CASP8 protein |
CTD |
PMID:24480042 |
|
NCBI chr 2:201,233,443...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
increases activity |
EXP |
mangostin results in increased activity of CASP9 protein |
CTD |
PMID:23954321 PMID:24480042 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CYCS |
cytochrome c, somatic |
increases expression |
EXP |
mangostin results in increased expression of CYCS protein |
CTD |
PMID:24480042 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions decreases expression affects response to substance |
EXP |
ESR1 protein affects the reaction [mangostin results in increased activity of CASP7 protein] mangostin results in decreased expression of ESR1 protein ESR1 protein affects the susceptibility to mangostin |
CTD |
PMID:24480042 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
increases phosphorylation |
EXP |
mangostin analog results in increased phosphorylation of MAP2K1 protein |
CTD |
PMID:28722351 |
|
NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656
|
|
G |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
increases phosphorylation |
EXP |
mangostin analog results in increased phosphorylation of MAP2K2 protein |
CTD |
PMID:28722351 |
|
NCBI chr19:4,090,321...4,124,122
Ensembl chr19:4,090,321...4,124,122
|
|
G |
MAP2K4 |
mitogen-activated protein kinase kinase 4 |
increases phosphorylation |
EXP |
mangostin analog results in increased phosphorylation of MAP2K4 protein |
CTD |
PMID:28722351 |
|
NCBI chr17:12,020,877...12,143,828
Ensembl chr17:12,020,829...12,143,830
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
EXP |
mangostin results in decreased expression of and results in decreased phosphorylation of MAPK1 protein mangostin analog results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:23954321 PMID:28722351 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP |
mangostin results in decreased expression of and results in decreased phosphorylation of MAPK3 protein mangostin analog results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:23954321 PMID:28722351 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
increases phosphorylation |
EXP |
mangostin analog results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:28722351 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
EXP |
mangostin analog results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:28722351 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [mangostin analog results in decreased expression of MMP2 protein]; pyrazolanthrone inhibits the reaction [mangostin analog results in decreased expression of MMP2 protein] mangostin analog results in decreased expression of MMP2 mRNA; mangostin analog results in decreased expression of MMP2 protein |
CTD |
PMID:28722351 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein]; pyrazolanthrone inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein] mangostin analog results in decreased expression of MMP9 mRNA; mangostin analog results in decreased expression of MMP9 protein |
CTD |
PMID:28722351 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases cleavage |
EXP |
mangostin results in increased cleavage of PARP1 protein |
CTD |
PMID:23954321 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
mangostin inhibits the reaction [Isoproterenol results in increased expression of PTGS2 protein] |
CTD |
PMID:18424012 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
TFF1 |
trefoil factor 1 |
decreases expression |
EXP |
mangostin results in decreased expression of TFF1 protein |
CTD |
PMID:24480042 |
|
NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
mangostin inhibits the reaction [Isoproterenol results in increased expression of TNF protein] |
CTD |
PMID:18424012 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TP53 |
tumor protein p53 |
increases expression multiple interactions |
EXP |
mangostin results in increased expression of TP53 protein mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of TP53 mRNA] |
CTD |
PMID:24480042 PMID:26357513 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions increases secretion increases export |
EXP ISO |
[carvedilol results in decreased activity of ABCB1 protein] which results in increased uptake of fluorexon; [Verapamil results in decreased activity of ABCB1 protein] which results in increased uptake of fluorexon; Beclomethasone inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Clotrimazole inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Cyclosporine inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; desisobutyrylciclesonide inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Ketoconazole inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Miconazole inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Mometasone Furoate inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Reserpine inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Troleandomycin inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of fluorexon] Amiodarone inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Clotrimazole inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Cyclosporine inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Ketoconazole inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Miconazole inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Reserpine inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Troleandomycin inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon] |
CTD |
PMID:10571255 PMID:12235267 PMID:16442095 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 |
affects export increases export increases import affects transport multiple interactions |
EXP ISO |
ABCC1 protein affects the export of fluorexon ABCC1 protein results in increased export of fluorexon ABCC1 protein results in increased import of fluorexon ABCC1 protein affects the transport of fluorexon Mefloquine inhibits the reaction [ABCC1 protein affects the export of fluorexon]; nobiletin promotes the reaction [ABCC1 protein results in increased import of fluorexon]; Quercetin inhibits the reaction [ABCC1 protein results in increased export of fluorexon]; robinetin inhibits the reaction [ABCC1 protein affects the export of fluorexon]; Silymarin inhibits the reaction [ABCC1 protein results in increased export of fluorexon]; verlukast inhibits the reaction [ABCC1 protein affects the export of fluorexon]; verlukast inhibits the reaction [ABCC1 protein results in increased export of fluorexon]; Vincristine inhibits the reaction [ABCC1 protein affects the transport of fluorexon] |
CTD |
PMID:10685512 PMID:15670588 PMID:16004972 PMID:16156793 PMID:18955043 PMID:26454883 More...
|
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
affects export increases abundance multiple interactions affects transport |
EXP |
ABCC2 protein affects the export of fluorexon ABCC2 protein alternative form results in increased abundance of fluorexon robinetin inhibits the reaction [ABCC2 protein affects the export of fluorexon] ABCC2 protein affects the transport of fluorexon |
CTD |
PMID:15670588 PMID:15848949 PMID:22027652 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ABCC6 |
ATP binding cassette subfamily C member 6 |
affects transport |
EXP |
ABCC6 affects the transport of fluorexon |
CTD |
PMID:14667841 |
|
NCBI chr16:16,149,565...16,223,494
Ensembl chr16:16,149,565...16,223,522
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions increases export increases activity affects export increases secretion increases transport |
EXP ISO |
2-methoxy-N-(3-(4-((3-methyl-4-((6-methyl-3-pyridinyl)oxy)phenyl)amino)-6-quinazolinyl)-2-propenyl)acetamide inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; [Endosulfan co-treated with Verapamil] inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; [phosalone co-treated with Verapamil] inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; [Verapamil binds to and results in decreased activity of ABCB1 protein] inhibits the reaction [sodium arsenite promotes the reaction [ABCB1 protein results in increased secretion of calcein AM]]; ABCB1 protein affects the reaction [Mifepristone results in decreased transport of calcein AM]; ABCB1 protein affects the reaction [zosuquidar trihydrochloride results in decreased transport of calcein AM]; Atorvastatin analog inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; chlorpyrifos-methyl affects the reaction [ABCB1 protein results in increased transport of calcein AM]; Cyclosporine inhibits the reaction [ABCB1 protein affects the export of calcein AM]; deoxynivalenol inhibits the reaction [valspodar inhibits the reaction [ABCB1 protein results in increased export of calcein AM]]; Diazinon inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Diazinon promotes the reaction [Endosulfan inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [phosalone inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Endosulfan inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Endosulfan inhibits the reaction [phosalone inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Endosulfan promotes the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; fenoxycarb inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; fenvalerate inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Lovastatin analog inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; phosalone inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; phosalone inhibits the reaction [Endosulfan inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; phosalone inhibits the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; propiconazole inhibits the reaction [phosalone inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; propiconazole promotes the reaction [Endosulfan inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; propiconazole promotes the reaction [Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Reserpine inhibits the reaction [ABCB1 protein affects the export of calcein AM]; Simvastatin analog inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; sodium arsenite promotes the reaction [ABCB1 protein results in increased secretion of calcein AM]; spinosad inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; valspodar inhibits the reaction [ABCB1 protein results in increased export of calcein AM]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of calcein AM]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Verapamil promotes the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]] ABCB1A protein promotes the reaction [Emodin results in increased export of calcein AM] calcein AM results in increased activity of ABCB1 protein mutant form |
CTD |
PMID:10617675 PMID:12711602 PMID:15616150 PMID:16121039 PMID:19223659 PMID:19549930 PMID:21321059 PMID:21783720 PMID:29174985 PMID:30217652 More...
|
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
affects export multiple interactions |
ISO |
ABCB11 protein affects the export of calcein AM ditekiren inhibits the reaction [ABCB11 protein affects the export of calcein AM] |
CTD |
PMID:10617675 |
|
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 |
increases transport multiple interactions |
EXP |
ABCC1 protein results in increased transport of calcein AM [ABCC1 protein results in increased susceptibility to Silver Nitrate] which results in decreased export of calcein AM; [ABCC1 protein results in increased susceptibility to Silver] which results in decreased export of calcein AM; [MYC protein results in increased expression of ABCC1 protein] which results in increased export of calcein AM; verlukast inhibits the reaction [ABCC1 protein results in increased transport of calcein AM]; zearalenol metabolite inhibits the reaction [ABCC1 protein results in increased transport of calcein AM]; Zearalenone inhibits the reaction [ABCC1 protein results in increased transport of calcein AM] |
CTD |
PMID:19239227 PMID:19647055 PMID:27376922 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
affects transport multiple interactions increases transport increases export |
EXP ISO |
ABCC2 protein affects the transport of calcein AM Atorvastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; Lovastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; Simvastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM] [MYC protein results in increased expression of ABCC2 protein] which results in increased export of calcein AM; Atorvastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; Lovastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; montelukast inhibits the reaction [ABCC2 protein results in increased export of calcein AM]; Simvastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; verlukast inhibits the reaction [ABCC2 protein results in increased export of calcein AM]; verlukast inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; zearalenol inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; Zearalenone inhibits the reaction [ABCC2 protein results in increased transport of calcein AM] |
CTD |
PMID:15210835 PMID:15616150 PMID:19239227 PMID:19647055 PMID:19952419 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ABCC3 |
ATP binding cassette subfamily C member 3 |
affects transport multiple interactions increases transport |
EXP |
ABCC3 protein affects the transport of calcein AM Dexamethasone promotes the reaction [ABCC3 protein affects the transport of calcein AM]; Glutathione promotes the reaction [ABCC3 protein affects the transport of calcein AM]; Hydrocortisone promotes the reaction [ABCC3 protein affects the transport of calcein AM]; Prednisone promotes the reaction [ABCC3 protein affects the transport of calcein AM]; verlukast inhibits the reaction [ABCC3 protein results in increased transport of calcein AM]; zearalenol inhibits the reaction [ABCC3 protein results in increased transport of calcein AM]; Zearalenone inhibits the reaction [ABCC3 protein results in increased transport of calcein AM] |
CTD |
PMID:15210835 PMID:15979871 PMID:19647055 |
|
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
|
|
G |
ABCC4 |
ATP binding cassette subfamily C member 4 |
multiple interactions |
EXP |
Glutathione promotes the reaction [ABCC4 protein affects the transport of calcein AM] |
CTD |
PMID:15210835 |
|
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
|
|
G |
ABCC6 |
ATP binding cassette subfamily C member 6 |
multiple interactions |
EXP |
Glutathione promotes the reaction [ABCC6 protein affects the transport of calcein AM] |
CTD |
PMID:15210835 |
|
NCBI chr16:16,149,565...16,223,494
Ensembl chr16:16,149,565...16,223,522
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
EXP |
[MYC protein results in increased expression of ABCC1 protein] which results in increased export of calcein AM; [MYC protein results in increased expression of ABCC2 protein] which results in increased export of calcein AM |
CTD |
PMID:19239227 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 |
decreases activity |
EXP |
Cannabinol results in decreased activity of ABCC1 protein |
CTD |
PMID:18619955 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
CNR1 |
cannabinoid receptor 1 |
affects binding |
ISO |
Cannabinol binds to CNR1 protein |
CTD |
PMID:19679411 |
|
NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
|
|
G |
CYP2J2 |
cytochrome P450 family 2 subfamily J member 2 |
increases metabolic processing multiple interactions |
EXP |
CYP2J2 protein results in increased metabolism of Cannabinol Cannabinol inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] |
CTD |
PMID:29689453 |
|
NCBI chr 1:59,893,308...59,969,212
Ensembl chr 1:59,893,308...59,926,773
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Cannabinol inhibits the reaction [[JUN protein binds to FOS protein] which binds to IL2 promoter]; Cannabinol results in decreased expression of and affects the localization of FOS protein |
CTD |
PMID:10670588 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
ISO |
Cannabinol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Rimonabant inhibits the reaction [Cannabinol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]] |
CTD |
PMID:11520904 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL2 |
interleukin 2 |
multiple interactions |
ISO |
Cannabinol inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL2 mRNA]; Cannabinol inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL2 protein]; Cannabinol inhibits the reaction [[JUN protein binds to FOS protein] which binds to IL2 promoter]; Cannabinol promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 mRNA]; Cannabinol promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL2 protein]; KN 93 inhibits the reaction [Cannabinol promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL2 protein]] |
CTD |
PMID:8662742 PMID:10670588 PMID:11809870 |
|
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Cannabinol inhibits the reaction [[JUN protein binds to FOS protein] which binds to IL2 promoter]; Cannabinol results in decreased expression of and affects the localization of JUN protein |
CTD |
PMID:10670588 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
PRL |
prolactin |
multiple interactions |
EXP |
Cannabinol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of PRL mRNA]; Cannabinol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased secretion of PRL protein] |
CTD |
PMID:31154070 |
|
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
Cannabinol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of and results in increased activity of STAT1 protein] |
CTD |
PMID:19910459 |
|
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
|
|
G |
TRPA1 |
transient receptor potential cation channel subfamily A member 1 |
multiple interactions increases activity |
EXP |
[Cannabinol results in increased activity of TRPA1 protein] which results in increased uptake of Calcium |
CTD |
PMID:31096838 |
|
NCBI chr 8:72,021,250...72,090,010
Ensembl chr 8:72,019,917...72,075,584
|
|
G |
TRPV2 |
transient receptor potential cation channel subfamily V member 2 |
multiple interactions |
ISO |
Cannabinol binds to and results in increased activity of TRPV2 protein |
CTD |
PMID:18550765 |
|
NCBI chr17:16,415,571...16,437,003
Ensembl chr17:16,415,571...16,437,003
|
|
|
G |
IFNB1 |
interferon beta 1 |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNB1 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
|
|
G |
IRF3 |
interferon regulatory factor 3 |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased expression of IRF3 protein] |
CTD |
PMID:31350693 |
|
NCBI chr19:49,659,572...49,665,857
Ensembl chr19:49,659,569...49,665,875
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides affects the phosphorylation of and affects the expression of and affects the localization of JUN protein] |
CTD |
PMID:31350693 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:31350693 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:31350693 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MYD88 |
MYD88 innate immune signal transduction adaptor |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,478...38,143,022
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein] |
CTD |
PMID:31350693 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,513...35,404,749
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] |
CTD |
PMID:31350693 |
|
NCBI chr11:65,653,601...65,662,916
Ensembl chr11:65,653,599...65,663,090
|
|
G |
TICAM1 |
TIR domain containing adaptor molecule 1 |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased expression of TICAM1 protein] |
CTD |
PMID:31350693 |
|
NCBI chr19:4,815,932...4,831,712
Ensembl chr19:4,815,932...4,831,712
|
|
G |
TLR4 |
toll like receptor 4 |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] |
CTD |
PMID:31350693 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 |
affects export |
ISO |
ABCC1 protein affects the export of Fluo-3 |
CTD |
PMID:15948026 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
multiple interactions increases secretion |
ISO |
Adenosine Triphosphate promotes the reaction [ABCC2 protein results in increased secretion of Fluo-3]; Cyclosporine inhibits the reaction [ABCC2 protein results in increased secretion of Fluo-3] |
CTD |
PMID:9794919 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
|
G |
CYP2C19 |
cytochrome P450 family 2 subfamily C member 19 |
multiple interactions |
EXP |
[CYP2C19 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein; Tranylcypromine inhibits the reaction [[CYP2C19 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein] |
CTD |
PMID:23850985 |
|
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
|
|
G |
CYP2C9 |
cytochrome P450 family 2 subfamily C member 9 |
multiple interactions |
EXP |
[CYP2C9 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein; Sulfaphenazole inhibits the reaction [[CYP2C9 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein] |
CTD |
PMID:23850985 |
|
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
|
|
G |
KCNH2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
EXP |
Fluorescein results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
|
|
G |
SLC22A6 |
solute carrier family 22 member 6 |
multiple interactions |
EXP |
Fluorescein inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] |
CTD |
PMID:11602689 |
|
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
|
|
G |
SLCO1B3 |
solute carrier organic anion transporter family member 1B3 |
increases uptake multiple interactions |
EXP |
SLCO1B3 protein results in increased uptake of Fluorescein bisphenol A inhibits the reaction [SLCO1B3 protein results in increased uptake of Fluorescein]; bisphenol F promotes the reaction [SLCO1B3 protein results in increased uptake of Fluorescein]; Probenecid inhibits the reaction [SLCO1B3 protein results in increased uptake of Fluorescein]; tetrabromobisphenol A inhibits the reaction [SLCO1B3 protein results in increased uptake of Fluorescein] |
CTD |
PMID:27989701 |
|
NCBI chr12:20,810,705...20,916,911
Ensembl chr12:20,810,702...20,916,911
|
|
G |
SLCO3A1 |
solute carrier organic anion transporter family member 3A1 |
increases uptake multiple interactions |
EXP |
SLCO3A1 protein results in increased uptake of Fluorescein Cyclosporine promotes the reaction [SLCO3A1 protein results in increased uptake of Fluorescein]; simvastatin acid affects the reaction [SLCO3A1 protein results in increased uptake of Fluorescein] |
CTD |
PMID:28887287 |
|
NCBI chr15:91,853,708...92,172,435
Ensembl chr15:91,853,708...92,172,435
|
|
G |
UGT2B15 |
UDP glucuronosyltransferase family 2 member B15 |
increases metabolic processing |
EXP |
UGT2B15 protein results in increased metabolism of Fluorescein |
CTD |
PMID:7835232 |
|
NCBI chr 4:68,646,597...68,670,652
Ensembl chr 4:68,646,597...68,670,652
|
|
|
G |
ABCB7 |
ATP binding cassette subfamily B member 7 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to ABCB7 protein |
CTD |
PMID:27129696 |
|
NCBI chr X:75,051,048...75,156,283
Ensembl chr X:75,051,048...75,156,732
|
|
G |
AKR1C2 |
aldo-keto reductase family 1 member C2 |
increases expression |
EXP |
Fluorescein-5-isothiocyanate results in increased expression of AKR1C2 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
|
|
G |
ANXA4 |
annexin A4 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to ANXA4 protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:69,643,808...69,827,112
Ensembl chr 2:69,644,425...69,827,112
|
|
G |
ARHGAP6 |
Rho GTPase activating protein 6 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to ARHGAP6 protein |
CTD |
PMID:27129696 |
|
NCBI chr X:11,137,544...11,665,920
Ensembl chr X:11,117,651...11,665,920
|
|
G |
AZI2 |
5-azacytidine induced 2 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to AZI2 protein |
CTD |
PMID:27129696 |
|
NCBI chr 3:28,321,047...28,348,824
Ensembl chr 3:28,315,003...28,349,050
|
|
G |
CAPZB |
capping actin protein of muscle Z-line subunit beta |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to CAPZB protein |
CTD |
PMID:27129696 |
|
NCBI chr 1:19,338,775...19,485,539
Ensembl chr 1:19,338,775...19,485,539
|
|
G |
CCNI2 |
cyclin I family member 2 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to CCNI2 protein |
CTD |
PMID:27129696 |
|
NCBI chr 5:132,747,426...132,756,065
Ensembl chr 5:132,747,426...132,754,403
|
|
G |
CD109 |
CD109 molecule |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to CD109 protein |
CTD |
PMID:27129696 |
|
NCBI chr 6:73,679,192...73,828,313
Ensembl chr 6:73,695,785...73,828,316
|
|
G |
CD180 |
CD180 molecule |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to CD180 protein |
CTD |
PMID:27129696 |
|
NCBI chr 5:67,179,613...67,196,799
Ensembl chr 5:67,179,613...67,196,799
|
|
G |
CD86 |
CD86 molecule |
increases expression |
EXP |
Fluorescein-5-isothiocyanate results in increased expression of CD86 protein |
CTD |
PMID:19665512 |
|
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
G |
CD93 |
CD93 molecule |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to CD93 protein |
CTD |
PMID:27129696 |
|
NCBI chr20:23,079,360...23,086,324
Ensembl chr20:23,079,360...23,086,324
|
|
G |
CDC20 |
cell division cycle 20 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to CDC20 protein |
CTD |
PMID:27129696 |
|
NCBI chr 1:43,358,981...43,363,203
Ensembl chr 1:43,358,981...43,363,203
|
|
G |
COPA |
COPI coat complex subunit alpha |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to COPA protein |
CTD |
PMID:27129696 |
|
NCBI chr 1:160,288,594...160,343,250
Ensembl chr 1:160,288,594...160,343,566
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases expression |
EXP |
Fluorescein-5-isothiocyanate results in increased expression of CYP1A1 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
DCAF4 |
DDB1 and CUL4 associated factor 4 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to DCAF4 protein |
CTD |
PMID:27129696 |
|
NCBI chr14:72,926,464...72,962,098
Ensembl chr14:72,926,377...72,959,703
|
|
G |
DOT1L |
DOT1 like histone lysine methyltransferase |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to DOT1L protein |
CTD |
PMID:27129696 |
|
NCBI chr19:2,163,933...2,232,578
Ensembl chr19:2,163,933...2,232,578
|
|
G |
ELAC1 |
elaC ribonuclease Z 1 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to ELAC1 protein |
CTD |
PMID:27129696 |
|
NCBI chr18:50,968,040...50,988,121
Ensembl chr18:50,967,991...50,988,121
|
|
G |
ENPP7 |
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to ENPP7 protein |
CTD |
PMID:27129696 |
|
NCBI chr17:79,730,943...79,742,219
Ensembl chr17:79,730,943...79,742,219
|
|
G |
FLRT3 |
fibronectin leucine rich transmembrane protein 3 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to FLRT3 protein |
CTD |
PMID:27129696 |
|
NCBI chr20:14,322,985...14,337,612
Ensembl chr20:14,322,985...14,337,614
|
|
G |
FN1 |
fibronectin 1 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to FN1 protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
[Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of HMOX1 protein Fluorescein-5-isothiocyanate results in increased expression of HMOX1 protein |
CTD |
PMID:27871981 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to HSPA5 protein |
CTD |
PMID:27129696 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
HSPA9 |
heat shock protein family A (Hsp70) member 9 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to HSPA9 protein |
CTD |
PMID:27129696 |
|
NCBI chr 5:138,553,756...138,575,401
Ensembl chr 5:138,553,756...138,575,675
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
ISO |
[Dibutyl Phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IFNG protein; [tributyrin co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IFNG protein |
CTD |
PMID:29198882 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to IKBKB protein |
CTD |
PMID:27129696 |
|
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
|
|
G |
IKZF4 |
IKAROS family zinc finger 4 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to IKZF4 protein |
CTD |
PMID:27129696 |
|
NCBI chr12:56,007,504...56,038,435
Ensembl chr12:56,007,659...56,038,435
|
|
G |
IL17RE |
interleukin 17 receptor E |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to IL17RE protein |
CTD |
PMID:27129696 |
|
NCBI chr 3:9,902,093...9,916,402
Ensembl chr 3:9,902,612...9,916,402
|
|
G |
IL31RA |
interleukin 31 receptor A |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to IL31RA protein |
CTD |
PMID:27129696 |
|
NCBI chr 5:55,839,789...55,922,850
Ensembl chr 5:55,851,357...55,922,854
|
|
G |
IL4 |
interleukin 4 |
increases expression multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of IL4 protein [Dibutyl Phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IL4 protein; [dibutyrylglycerol analog co-treated with Fluorescein-5-isothiocyanate] affects the secretion of IL4 protein; [tributyrin co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IL4 protein; diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL4 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL4 protein]] |
CTD |
PMID:27871981 PMID:29198882 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
LYPD3 |
LY6/PLAUR domain containing 3 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to LYPD3 protein |
CTD |
PMID:27129696 |
|
NCBI chr19:43,460,787...43,465,608
Ensembl chr19:43,460,787...43,465,608
|
|
G |
MAFF |
MAF bZIP transcription factor F |
increases expression |
EXP |
Fluorescein-5-isothiocyanate results in increased expression of MAFF mRNA |
CTD |
PMID:20491607 |
|
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
|
|
G |
MAP3K20 |
mitogen-activated protein kinase kinase kinase 20 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to MAP3K20 protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:173,075,517...173,268,015
Ensembl chr 2:173,075,435...173,268,015
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
increases phosphorylation multiple interactions |
EXP |
Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK1 protein Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK1 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:27129696 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP |
Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK3 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:27129696 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
increases phosphorylation multiple interactions |
EXP |
Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK8 protein Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK8 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:27129696 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
multiple interactions increases phosphorylation |
EXP |
Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK9 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:27129696 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MT2A |
metallothionein 2A |
increases expression |
EXP |
Fluorescein-5-isothiocyanate results in increased expression of MT2A mRNA |
CTD |
PMID:20491607 |
|
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
|
|
G |
MYBPC1 |
myosin binding protein C1 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to MYBPC1 protein |
CTD |
PMID:27129696 |
|
NCBI chr12:101,594,971...101,695,841
Ensembl chr12:101,568,353...101,686,028
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
[Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of NFE2L2 protein |
CTD |
PMID:27871981 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,227,595...177,392,697
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression multiple interactions |
EXP ISO |
Fluorescein-5-isothiocyanate results in increased expression of NQO1 mRNA diisodecyl phthalate inhibits the reaction [Fluorescein-5-isothiocyanate results in increased expression of NQO1 protein]; Melatonin inhibits the reaction [diisodecyl phthalate inhibits the reaction [Fluorescein-5-isothiocyanate results in increased expression of NQO1 protein]] |
CTD |
PMID:20491607 PMID:27871981 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
PARP15 |
poly(ADP-ribose) polymerase family member 15 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to PARP15 protein |
CTD |
PMID:27129696 |
|
NCBI chr 3:122,577,650...122,639,047
Ensembl chr 3:122,577,628...122,639,047
|
|
G |
PLCE1 |
phospholipase C epsilon 1 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to PLCE1 protein |
CTD |
PMID:27129696 |
|
NCBI chr10:93,993,931...94,332,823
Ensembl chr10:93,993,931...94,332,823
|
|
G |
POSTN |
periostin |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to POSTN protein |
CTD |
PMID:27129696 |
|
NCBI chr13:37,562,585...37,598,768
Ensembl chr13:37,562,583...37,598,844
|
|
G |
PPRC1 |
PPARG related coactivator 1 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to PPRC1 protein |
CTD |
PMID:27129696 |
|
NCBI chr10:102,119,889...102,150,333
Ensembl chr10:102,132,994...102,150,333
|
|
G |
PRKCB |
protein kinase C beta |
increases expression |
EXP |
Fluorescein-5-isothiocyanate results in increased expression of PRKCB protein |
CTD |
PMID:31958493 |
|
NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611
|
|
G |
PSD4 |
pleckstrin and Sec7 domain containing 4 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to PSD4 protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:113,173,971...113,209,391
Ensembl chr 2:113,157,325...113,209,396
|
|
G |
PSMD14 |
proteasome 26S subunit, non-ATPase 14 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to PSMD14 protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:161,308,425...161,411,717
Ensembl chr 2:161,308,425...161,411,717
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
[diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased phosphorylation of RELA protein; Melatonin inhibits the reaction [[diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased phosphorylation of RELA protein] |
CTD |
PMID:27871981 |
|
NCBI chr11:65,653,601...65,662,916
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SCN5A |
sodium voltage-gated channel alpha subunit 5 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to SCN5A protein |
CTD |
PMID:27129696 |
|
NCBI chr 3:38,548,062...38,649,687
Ensembl chr 3:38,548,057...38,649,687
|
|
G |
SKOR1 |
SKI family transcriptional corepressor 1 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to SKOR1 protein |
CTD |
PMID:27129696 |
|
NCBI chr15:67,825,509...67,834,582
Ensembl chr15:67,819,704...67,834,582
|
|
G |
SLC38A10 |
solute carrier family 38 member 10 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to SLC38A10 protein |
CTD |
PMID:27129696 |
|
NCBI chr17:81,244,811...81,295,307
Ensembl chr17:81,244,811...81,295,547
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
increases phosphorylation multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein]] |
CTD |
PMID:27871981 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,540
|
|
G |
STAT5A |
signal transducer and activator of transcription 5A |
increases phosphorylation multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT5 protein diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT5 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT5 protein]] |
CTD |
PMID:27871981 |
|
NCBI chr17:42,287,547...42,311,943
Ensembl chr17:42,287,547...42,311,943
|
|
G |
STAT6 |
signal transducer and activator of transcription 6 |
increases phosphorylation multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT6 protein diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT6 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT6 protein]] |
CTD |
PMID:27871981 |
|
NCBI chr12:57,095,408...57,111,362
Ensembl chr12:57,095,408...57,132,139
|
|
G |
TRPA1 |
transient receptor potential cation channel subfamily A member 1 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to TRPA1 protein |
CTD |
PMID:27129696 |
|
NCBI chr 8:72,021,250...72,090,010
Ensembl chr 8:72,019,917...72,075,584
|
|
G |
TSLP |
thymic stromal lymphopoietin |
increases expression multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of TSLP protein diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TSLP protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TSLP protein]] |
CTD |
PMID:27871981 |
|
NCBI chr 5:111,070,062...111,078,026
Ensembl chr 5:111,070,062...111,078,026
|
|
G |
TXN |
thioredoxin |
increases expression |
EXP |
Fluorescein-5-isothiocyanate results in increased expression of TXN mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
|
|
G |
USP3 |
ubiquitin specific peptidase 3 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to USP3 protein |
CTD |
PMID:27129696 |
|
NCBI chr15:63,504,593...63,594,633
Ensembl chr15:63,504,511...63,594,640
|
|
G |
ZNF256 |
zinc finger protein 256 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to ZNF256 protein |
CTD |
PMID:27129696 |
|
NCBI chr19:57,940,833...57,947,706
Ensembl chr19:57,940,833...57,947,706
|
|
G |
ZNF836 |
zinc finger protein 836 |
affects binding |
EXP |
Fluorescein-5-isothiocyanate binds to ZNF836 protein |
CTD |
PMID:27129696 |
|
NCBI chr19:52,154,107...52,171,621
Ensembl chr19:52,153,864...52,171,643
|
|
|
G |
SLC2A4 |
solute carrier family 2 member 4 |
multiple interactions |
ISO |
gallein inhibits the reaction [Chloroquine affects the localization of SLC2A4 protein] |
CTD |
PMID:27160165 |
|
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
|
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
multiple interactions decreases expression |
ISO EXP |
gamma-mangostin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] [gamma-mangostin co-treated with MK 2206] results in decreased expression of ACTA2 protein; diphenyleneiodonium promotes the reaction [gamma-mangostin results in decreased expression of ACTA2 protein]; gamma-mangostin promotes the reaction [diphenyleneiodonium results in decreased expression of ACTA2 protein]; SIRT3 protein affects the reaction [gamma-mangostin results in decreased expression of ACTA2 protein] |
CTD |
PMID:30502394 |
|
NCBI chr10:88,935,074...88,991,397
Ensembl chr10:88,935,074...88,991,339
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions |
EXP |
gamma-mangostin results in decreased phosphorylation of AKT1 protein [gamma-mangostin co-treated with MK 2206] results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:30502394 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
gamma-mangostin inhibits the reaction [Carbon Tetrachloride results in increased expression of GPT protein] |
CTD |
PMID:30502394 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
HDAC1 |
histone deacetylase 1 |
increases expression |
EXP |
gamma-mangostin results in increased expression of HDAC1 protein |
CTD |
PMID:30502394 |
|
NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
|
|
G |
HMGB1 |
high mobility group box 1 |
decreases secretion multiple interactions |
EXP ISO |
gamma-mangostin results in decreased secretion of HMGB1 protein gamma-mangostin inhibits the reaction [Carbon Tetrachloride results in increased expression of HMGB1 protein] diphenyleneiodonium promotes the reaction [gamma-mangostin results in decreased secretion of HMGB1 protein]; gamma-mangostin affects the localization of and results in decreased acetylation of HMGB1 protein; gamma-mangostin promotes the reaction [diphenyleneiodonium results in decreased secretion of HMGB1 protein]; SIRT3 protein affects the reaction [gamma-mangostin results in decreased secretion of HMGB1 protein] |
CTD |
PMID:30502394 |
|
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
|
|
G |
SIRT3 |
sirtuin 3 |
multiple interactions increases expression |
EXP ISO |
SIRT3 protein affects the reaction [gamma-mangostin results in decreased expression of ACTA2 protein]; SIRT3 protein affects the reaction [gamma-mangostin results in decreased secretion of HMGB1 protein] gamma-mangostin results in increased expression of SIRT3 protein [gamma-mangostin co-treated with Carbon Tetrachloride] results in increased expression of and results in increased secretion of SIRT3 protein |
CTD |
PMID:30502394 |
|
NCBI chr11:215,030...236,931
Ensembl chr11:215,030...236,931
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions increases expression |
EXP |
Dichlororibofuranosylbenzimidazole inhibits the reaction [mangiferin results in increased expression of ABCB1 protein] mangiferin results in increased expression of ABCB1 mRNA; mangiferin results in increased expression of ABCB1 protein |
CTD |
PMID:20513373 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABL1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
decreases expression |
EXP |
mangiferin results in decreased expression of ABL1 mRNA |
CTD |
PMID:15498116 |
|
NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,016...130,887,675
|
|
G |
ACACA |
acetyl-CoA carboxylase alpha |
multiple interactions increases phosphorylation |
ISO |
dorsomorphin inhibits the reaction [mangiferin results in increased phosphorylation of ACACA protein] |
CTD |
PMID:22292039 |
|
NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
|
|
G |
ACHE |
acetylcholinesterase (Cartwright blood group) |
decreases activity multiple interactions |
ISO |
mangiferin results in decreased activity of ACHE protein mangiferin inhibits the reaction [Scopolamine results in decreased expression of ACHE protein] |
CTD |
PMID:19182383 PMID:22426032 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
ACP5 |
acid phosphatase 5, tartrate resistant |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr19:11,574,660...11,578,975
Ensembl chr19:11,574,653...11,579,993
|
|
G |
ADRB3 |
adrenoceptor beta 3 |
multiple interactions |
ISO |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADRB3 protein |
CTD |
PMID:32417366 |
|
NCBI chr 8:37,962,990...37,966,599
Ensembl chr 8:37,962,990...37,966,599
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
decreases expression |
ISO |
mangiferin results in decreased expression of AGER mRNA; mangiferin results in decreased expression of AGER protein |
CTD |
PMID:24036348 |
|
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
|
|
G |
AGT |
angiotensinogen |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of AGTR1A mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of AGTR1A protein]; mangiferin inhibits the reaction [AGT protein results in increased expression of COL1A1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of COL4A1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of FN1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of FN1 protein]; mangiferin inhibits the reaction [AGT protein results in increased expression of SERPINE1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of TGFB1 protein] |
CTD |
PMID:17645561 PMID:19706694 |
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
AGTR1 |
angiotensin II receptor type 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in increased expression of AGTR1A mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of AGTR1A protein] |
CTD |
PMID:17645561 PMID:19706694 |
|
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Excitatory Amino Acid Agonists affects the localization of AIFM1 protein] |
CTD |
PMID:19201465 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO EXP |
mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in decreased phosphorylation of AKT1 protein] mangiferin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:19201465 PMID:22465218 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
ALB |
albumin |
affects binding |
EXP |
mangiferin binds to ALB protein |
CTD |
PMID:19157745 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
APAF1 |
apoptotic peptidase activating factor 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [lead nitrate results in decreased expression of APAF1 protein] |
CTD |
PMID:23451106 |
|
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,290...98,735,433
|
|
G |
ATP6V0D2 |
ATPase H+ transporting V0 subunit d2 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ATP6V0D2 mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr 8:86,098,910...86,154,225
Ensembl chr 8:85,987,323...86,154,225
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in increased expression of BAX protein] mangiferin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of BAX protein]; mangiferin inhibits the reaction [lead nitrate results in increased expression of BAX protein] |
CTD |
PMID:19201465 PMID:23451106 PMID:24095822 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
EXP ISO |
mangiferin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] mangiferin inhibits the reaction [Galactosamine results in decreased expression of BCL2 protein] mangiferin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]; mangiferin inhibits the reaction [lead nitrate results in decreased expression of BCL2 protein] |
CTD |
PMID:21420233 PMID:22118634 PMID:23451106 PMID:24095822 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
decreases expression |
EXP |
mangiferin results in decreased expression of BCL2L1 protein |
CTD |
PMID:21547680 PMID:26996543 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BIRC5 |
baculoviral IAP repeat containing 5 |
decreases expression |
EXP |
mangiferin results in decreased expression of BIRC5 protein |
CTD |
PMID:26996543 |
|
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
|
|
G |
C3 |
complement C3 |
decreases expression |
ISO |
mangiferin results in decreased expression of C3 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
CALCR |
calcitonin receptor |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr 7:93,424,486...93,574,724
Ensembl chr 7:93,424,486...93,574,730
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases activity |
ISO EXP |
mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP3 protein] mangiferin results in increased activity of CASP3 protein mangiferin inhibits the reaction [Galactosamine results in increased expression of CASP3 protein] |
CTD |
PMID:21547680 PMID:22118634 PMID:22310181 PMID:23451106 PMID:26996543 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
|
|
G |
CASP8 |
caspase 8 |
increases expression |
EXP |
mangiferin results in increased expression of CASP8 protein |
CTD |
PMID:32420661 |
|
NCBI chr 2:201,233,443...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP9 protein] mangiferin inhibits the reaction [Galactosamine results in increased expression of CASP9 protein] |
CTD |
PMID:22118634 PMID:23451106 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions increases activity |
ISO EXP |
mangiferin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CAT mRNA]; mangiferin inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein]; mangiferin inhibits the reaction [Dextran Sulfate results in decreased activity of CAT protein]; mangiferin inhibits the reaction [lead nitrate results in decreased activity of CAT protein] mangiferin inhibits the reaction [Mercuric Chloride results in decreased expression of CAT protein] mangiferin inhibits the reaction [Cyclophosphamide results in decreased activity of CAT protein]; mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in decreased activity of CAT protein]; mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; mangiferin inhibits the reaction [Streptozocin results in decreased activity of CAT protein] mangiferin results in increased activity of CAT protein |
CTD |
PMID:15161907 PMID:16076520 PMID:16584858 PMID:16697266 PMID:17433543 PMID:18816296 PMID:19201465 PMID:20629087 PMID:23451106 PMID:27125760 PMID:29223569 More...
|
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
decreases expression |
ISO |
mangiferin results in decreased expression of CCL2 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein] |
CTD |
PMID:15135318 |
|
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CCNB1 |
cyclin B1 |
increases expression |
EXP |
mangiferin results in increased expression of CCNB1 mRNA |
CTD |
PMID:20518311 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CD36 |
CD36 molecule |
multiple interactions increases expression |
ISO |
dorsomorphin inhibits the reaction [mangiferin results in increased expression of CD36 protein] |
CTD |
PMID:22292039 |
|
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
|
|
G |
CDH1 |
cadherin 1 |
increases expression affects expression multiple interactions |
EXP |
mangiferin results in increased expression of CDH1 protein mangiferin affects the expression of CDH1 protein lipopolysaccharide, Escherichia coli O111 B4 affects the reaction [mangiferin affects the expression of CDH1 protein] |
CTD |
PMID:23707762 PMID:32420661 |
|
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
increases expression |
EXP |
mangiferin results in increased expression of CDK1 mRNA |
CTD |
PMID:20518311 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CHUK |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
EXP ISO |
mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein] mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of CHUK protein] mangiferin inhibits the reaction [Galactosamine results in increased phosphorylation of CHUK protein] |
CTD |
PMID:21420233 PMID:22310181 PMID:23451106 |
|
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
|
|
G |
CIDEA |
cell death inducing DFFA like effector a |
multiple interactions |
ISO |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA |
CTD |
PMID:32417366 |
|
NCBI chr18:12,254,361...12,277,595
Ensembl chr18:12,254,361...12,277,595
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in increased expression of COL1A1 mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
COL4A1 |
collagen type IV alpha 1 chain |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in increased expression of COL4A1 mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr13:110,148,963...110,307,157
Ensembl chr13:110,148,963...110,307,157
|
|
G |
CPT1A |
carnitine palmitoyltransferase 1A |
increases expression multiple interactions |
ISO |
mangiferin results in increased expression of CPT1A protein dorsomorphin inhibits the reaction [mangiferin results in increased expression of CPT1A protein] |
CTD |
PMID:22292039 |
|
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
|
|
G |
CSF2 |
colony stimulating factor 2 |
multiple interactions decreases expression |
ISO |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 protein] mangiferin results in decreased expression of CSF2 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CSF3 |
colony stimulating factor 3 |
multiple interactions decreases expression |
ISO |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF3 protein] mangiferin results in decreased expression of CSF3 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
|
|
G |
CTNNB1 |
catenin beta 1 |
decreases response to substance |
EXP |
CTNNB1 protein results in decreased susceptibility to mangiferin |
CTD |
PMID:23707762 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CTNND1 |
catenin delta 1 |
multiple interactions |
EXP |
mangiferin inhibits the reaction [Paraquat results in decreased expression of and affects the localization of CTNND1 protein]; mangiferin inhibits the reaction [Paraquat results in decreased expression of CTNND1 mRNA alternative form] |
CTD |
PMID:24912632 |
|
NCBI chr11:57,761,802...57,819,540
Ensembl chr11:57,753,243...57,819,546
|
|
G |
CTSD |
cathepsin D |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein] |
CTD |
PMID:19172585 |
|
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
|
|
G |
CTSK |
cathepsin K |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr 1:150,796,208...150,808,260
Ensembl chr 1:150,794,880...150,809,577
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions affects expression |
EXP ISO |
mangiferin inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein] mangiferin affects the expression of CXCL15 protein |
CTD |
PMID:21420233 PMID:21837981 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CXCR4 |
C-X-C motif chemokine receptor 4 |
multiple interactions |
EXP |
mangiferin affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of CXCR4 protein]; mangiferin inhibits the reaction [TNF protein results in increased expression of CXCR4 mRNA] |
CTD |
PMID:21420233 PMID:32420661 |
|
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases expression |
EXP |
mangiferin results in increased expression of CYP1A1 mRNA |
CTD |
PMID:22815239 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
decreases activity increases expression |
ISO EXP |
mangiferin results in decreased activity of CYP1A2 protein mangiferin results in increased expression of CYP1A2 mRNA |
CTD |
PMID:18053976 PMID:22815239 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
decreases activity |
EXP |
mangiferin results in decreased activity of CYP2A6 protein |
CTD |
PMID:22815239 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
CYP2C19 |
cytochrome P450 family 2 subfamily C member 19 |
decreases activity |
ISO |
mangiferin results in decreased activity of CYP2C6V1 protein |
CTD |
PMID:18053976 |
|
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
|
|
G |
CYP2C9 |
cytochrome P450 family 2 subfamily C member 9 |
decreases activity |
EXP |
mangiferin results in decreased activity of CYP2C9 protein |
CTD |
PMID:22815239 |
|
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
|
|
G |
CYP2D6 |
cytochrome P450 family 2 subfamily D member 6 |
decreases activity |
EXP |
mangiferin results in decreased activity of CYP2D6 protein |
CTD |
PMID:22815239 |
|
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
decreases activity |
ISO |
mangiferin results in decreased activity of CYP2E1 protein |
CTD |
PMID:18053976 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
decreases activity |
EXP |
mangiferin results in decreased activity of CYP3A4 protein |
CTD |
PMID:22815239 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
DCSTAMP |
dendrocyte expressed seven transmembrane protein |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr 8:104,339,796...104,356,689
Ensembl chr 8:104,339,087...104,356,689
|
|
G |
DGAT2 |
diacylglycerol O-acyltransferase 2 |
decreases expression affects expression multiple interactions |
ISO |
mangiferin results in decreased expression of DGAT2 protein mangiferin affects the expression of DGAT2 mRNA; mangiferin affects the expression of DGAT2 protein dorsomorphin inhibits the reaction [mangiferin results in increased expression of DGAT2 protein] |
CTD |
PMID:22292039 PMID:25123789 |
|
NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
|
|
G |
DNM1L |
dynamin 1 like |
multiple interactions |
EXP |
mangiferin inhibits the reaction [Methylmercury Compounds results in increased expression of and results in increased phosphorylation of DNM1L protein] |
CTD |
PMID:28071871 |
|
NCBI chr12:32,679,301...32,745,650
Ensembl chr12:32,679,200...32,745,650
|
|
G |
F10 |
coagulation factor X |
decreases activity |
EXP |
mangiferin analog results in decreased activity of F10 protein |
CTD |
PMID:21732671 |
|
NCBI chr13:113,122,799...113,149,529
Ensembl chr13:113,122,799...113,149,529
|
|
G |
FAS |
Fas cell surface death receptor |
increases expression |
EXP |
mangiferin results in increased expression of FAS protein |
CTD |
PMID:17634039 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FBP1 |
fructose-bisphosphatase 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of FBP1 mRNA |
CTD |
PMID:19028559 |
|
NCBI chr 9:94,603,133...94,640,263
Ensembl chr 9:94,603,133...94,640,249
|
|
G |
FN1 |
fibronectin 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in increased expression of FN1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of FN1 protein] |
CTD |
PMID:19706694 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
GCG |
glucagon |
multiple interactions |
ISO |
[mangiferin co-treated with Sitagliptin Phosphate] results in increased expression of GCG protein alternative form |
CTD |
PMID:22948814 |
|
NCBI chr 2:162,142,882...162,152,247
Ensembl chr 2:162,142,882...162,152,404
|
|
G |
GLO1 |
glyoxalase I |
increases expression multiple interactions |
ISO |
mangiferin results in increased expression of GLO1 mRNA mangiferin results in increased expression of and results in increased activity of GLO1 protein |
CTD |
PMID:24036348 |
|
NCBI chr 6:38,675,925...38,703,145
Ensembl chr 6:38,675,925...38,703,145
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Streptozocin results in increased activity of GPT protein] |
CTD |
PMID:29223569 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions |
ISO EXP |
mangiferin inhibits the reaction [Benzo(a)pyrene results in decreased activity of GSR protein]; mangiferin inhibits the reaction [lead nitrate results in decreased activity of GSR protein] mangiferin inhibits the reaction [Methylmercury Compounds results in decreased activity of GSR protein] mangiferin inhibits the reaction [Isoproterenol results in decreased activity of GSR protein] |
CTD |
PMID:16697266 PMID:18816296 PMID:23451106 PMID:28071871 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
GUSB |
glucuronidase beta |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Isoproterenol results in decreased activity of GUSB protein] |
CTD |
PMID:19172585 |
|
NCBI chr 7:65,960,684...65,982,213
Ensembl chr 7:65,960,684...65,982,215
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Galactosamine results in decreased expression of HMOX1 protein] |
CTD |
PMID:22310181 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
multiple interactions decreases expression |
EXP ISO |
mangiferin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] mangiferin results in decreased expression of ICAM1 mRNA |
CTD |
PMID:15135318 PMID:15161907 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
ICAM2 |
intercellular adhesion molecule 2 |
decreases expression |
ISO |
mangiferin results in decreased expression of ICAM2 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr17:64,002,595...64,020,633
Ensembl chr17:64,002,594...64,020,634
|
|
G |
ICAM5 |
intercellular adhesion molecule 5 |
decreases expression |
ISO |
mangiferin results in decreased expression of ICAM5 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr19:10,289,952...10,296,778
Ensembl chr19:10,289,952...10,296,778
|
|
G |
IFNA1 |
interferon alpha 1 |
increases expression |
ISO |
mangiferin results in increased expression of IFNA1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 9:21,440,439...21,441,316
Ensembl chr 9:21,440,439...21,441,316
|
|
G |
IFNB1 |
interferon beta 1 |
increases expression |
ISO |
mangiferin results in increased expression of IFNB1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
ISO |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Leukotriene B4]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF3 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of TNF protein]; mangiferin promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TGFB1 mRNA] mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [Galactosamine results in increased expression of IFNG mRNA] |
CTD |
PMID:12694877 PMID:15135318 PMID:15177302 PMID:15177305 PMID:15222974 PMID:16716910 PMID:22310181 More...
|
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
EXP ISO |
mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of IKBKB protein] mangiferin inhibits the reaction [Galactosamine results in increased phosphorylation of IKBKB protein] |
CTD |
PMID:21420233 PMID:22310181 |
|
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Galactosamine results in decreased expression of IL10 mRNA] |
CTD |
PMID:22310181 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL12A |
interleukin 12A |
decreases expression |
ISO |
mangiferin results in decreased expression of IL12A mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
|
|
G |
IL12B |
interleukin 12B |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Galactosamine results in increased expression of IL12B mRNA] |
CTD |
PMID:22310181 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL18 |
interleukin 18 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Galactosamine results in increased expression of IL18 mRNA] |
CTD |
PMID:22310181 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
|
|
G |
IL1A |
interleukin 1 alpha |
decreases expression |
ISO |
mangiferin results in decreased expression of IL1A mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Galactosamine results in increased expression of IL1B mRNA]; mangiferin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein]; mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein] |
CTD |
PMID:15381052 PMID:22310181 PMID:27125760 PMID:27474068 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL2RB |
interleukin 2 receptor subunit beta |
decreases expression |
ISO |
mangiferin results in decreased expression of IL2RB mRNA |
CTD |
PMID:15135318 |
|
NCBI chr22:37,125,838...37,175,118
Ensembl chr22:37,125,843...37,175,054
|
|
G |
IL6 |
interleukin 6 |
multiple interactions decreases expression |
EXP ISO |
mangiferin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]; mangiferin inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased secretion of IL6 protein] mangiferin inhibits the reaction [Galactosamine results in increased expression of IL6 mRNA] mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 protein]; mangiferin inhibits the reaction [Ketamine results in increased expression of IL6 protein] mangiferin results in decreased expression of IL6 mRNA |
CTD |
PMID:15135318 PMID:21420233 PMID:22310181 PMID:23087136 PMID:27474068 PMID:32420661 More...
|
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IRF1 |
interferon regulatory factor 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of IRF1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
|
|
G |
LPL |
lipoprotein lipase |
multiple interactions increases activity increases expression |
EXP |
MK-886 inhibits the reaction [mangiferin results in increased activity of LPL protein]; MK-886 inhibits the reaction [mangiferin results in increased expression of LPL mRNA] |
CTD |
PMID:15975614 |
|
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
|
|
G |
MAP3K14 |
mitogen-activated protein kinase kinase kinase 14 |
decreases phosphorylation |
EXP |
mangiferin results in decreased phosphorylation of MAP3K14 protein |
CTD |
PMID:26996543 |
|
NCBI chr17:45,263,119...45,317,020
Ensembl chr17:45,263,119...45,317,029
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
increases phosphorylation decreases activity affects binding multiple interactions |
ISO EXP |
mangiferin results in increased phosphorylation of MAPK1 protein mangiferin metabolite results in decreased activity of MAPK1 protein mangiferin metabolite binds to MAPK1 protein mangiferin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of MAPK1 protein] mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]; mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:19201465 PMID:20683903 PMID:22084399 PMID:22465218 PMID:23451106 PMID:27474068 More...
|
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions decreases activity increases phosphorylation |
ISO EXP |
mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]; mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein] mangiferin metabolite results in decreased activity of MAPK3 protein mangiferin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of MAPK3 protein] mangiferin results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:19201465 PMID:20683903 PMID:22084399 PMID:22465218 PMID:23451106 PMID:27474068 More...
|
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
decreases expression |
ISO |
mangiferin results in decreased expression of MAPK8 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
decreases expression |
ISO |
mangiferin results in decreased expression of MAPK9 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MAX |
MYC associated factor X |
decreases expression |
ISO |
mangiferin results in decreased expression of MAX mRNA |
CTD |
PMID:15135318 |
|
NCBI chr14:65,006,101...65,102,695
Ensembl chr14:65,006,174...65,102,695
|
|
G |
MMP7 |
matrix metallopeptidase 7 |
decreases expression |
EXP |
mangiferin results in decreased expression of MMP7 protein |
CTD |
PMID:23707762 |
|
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
decreases expression multiple interactions decreases activity |
EXP ISO |
mangiferin results in decreased expression of MMP9 mRNA; mangiferin results in decreased expression of MMP9 protein mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 protein] mangiferin results in decreased expression of and results in decreased secretion of MMP9 protein mangiferin results in decreased activity of MMP9 protein |
CTD |
PMID:22465218 PMID:23707762 PMID:27125760 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MPO |
myeloperoxidase |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein] |
CTD |
PMID:27125760 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
mangiferin affects the reaction [Galactosamine affects the localization of NFE2L2 protein]; mangiferin inhibits the reaction [Galactosamine results in decreased expression of NFE2L2 protein] |
CTD |
PMID:22310181 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,227,595...177,392,697
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
EXP |
mangiferin inhibits the reaction [TNF protein affects the localization of and results in increased activity of NFKB1 protein] |
CTD |
PMID:15161907 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,331...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions increases expression |
EXP ISO |
mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein] mangiferin inhibits the reaction [Galactosamine results in decreased expression of NFKBIA protein] mangiferin results in increased expression of NFKBIA protein mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of NFKBIA protein]; mangiferin inhibits the reaction [lead nitrate results in decreased expression of NFKBIA protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased degradation of NFKBIA protein] |
CTD |
PMID:15161907 PMID:20683903 PMID:22310181 PMID:23451106 PMID:27474068 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,513...35,404,749
|
|
G |
NFKBIB |
NFKB inhibitor beta |
decreases expression multiple interactions |
ISO EXP |
mangiferin results in decreased expression of NFKBIB mRNA mangiferin inhibits the reaction [TNF protein results in increased degradation of NFKBIB protein] |
CTD |
PMID:15135318 PMID:21420233 |
|
NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893
|
|
G |
NFKBIE |
NFKB inhibitor epsilon |
decreases expression |
ISO |
mangiferin results in decreased expression of NFKBIE mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 6:44,258,166...44,265,551
Ensembl chr 6:44,258,166...44,265,788
|
|
G |
NFKBIL1 |
NFKB inhibitor like 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of NFKBIL1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 6:31,546,851...31,558,829
Ensembl chr 6:31,546,870...31,558,829
|
|
G |
NGF |
nerve growth factor |
increases secretion |
EXP |
mangiferin results in increased secretion of NGF protein |
CTD |
PMID:20303935 |
|
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
|
|
G |
NLRP3 |
NLR family pyrin domain containing 3 |
multiple interactions |
EXP |
mangiferin affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of NLRP3 protein] |
CTD |
PMID:32420661 |
|
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of NOS2 mRNA]; mangiferin inhibits the reaction [Galactosamine results in increased expression of NOS2 protein]; mangiferin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; mangiferin promotes the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNFB protein] results in increased expression of NOS2 mRNA] |
CTD |
PMID:12694877 PMID:15381052 PMID:22118634 PMID:22310181 PMID:27474068 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Galactosamine results in decreased expression of NQO1 protein] |
CTD |
PMID:22310181 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
PER1 |
period circadian regulator 1 |
multiple interactions affects expression |
EXP |
mangiferin affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of PER1 protein] mangiferin affects the expression of PER1 protein |
CTD |
PMID:32420661 |
|
NCBI chr17:8,140,472...8,152,404
Ensembl chr17:8,140,472...8,156,506
|
|
G |
PLA2G2A |
phospholipase A2 group IIA |
decreases activity |
EXP |
mangiferin results in decreased activity of PLA2G2A protein |
CTD |
PMID:15177302 |
|
NCBI chr 1:19,975,431...19,980,434
Ensembl chr 1:19,975,431...19,980,416
|
|
G |
PLAU |
plasminogen activator, urokinase |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
multiple interactions increases activity |
EXP ISO |
MK-886 inhibits the reaction [mangiferin results in increased activity of PPARA protein] [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARA mRNA |
CTD |
PMID:15975614 PMID:32417366 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]; mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein |
CTD |
PMID:29223569 PMID:32417366 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PPARGC1A |
PPARG coactivator 1 alpha |
multiple interactions |
ISO |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARGC1A mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARGC1A protein |
CTD |
PMID:32417366 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
G |
PRDM16 |
PR/SET domain 16 |
multiple interactions |
ISO |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PRDM16 mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PRDM16 protein |
CTD |
PMID:32417366 |
|
NCBI chr 1:3,069,203...3,438,621
Ensembl chr 1:3,069,168...3,438,621
|
|
G |
PRKAA1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions |
ISO |
dorsomorphin inhibits the reaction [mangiferin results in increased phosphorylation of and results in increased activity of PRKAA1 protein]; mangiferin results in increased phosphorylation of and results in increased activity of PRKAA1 protein |
CTD |
PMID:22292039 |
|
NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions affects expression |
EXP ISO |
mangiferin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein] mangiferin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; mangiferin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] mangiferin affects the expression of PTGS2 mRNA |
CTD |
PMID:15161907 PMID:15381052 PMID:18621015 PMID:19026997 PMID:21420233 PMID:27474068 More...
|
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
decreases expression |
ISO |
mangiferin results in decreased expression of RAF1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions affects localization decreases expression decreases localization |
EXP ISO |
mangiferin inhibits the reaction [TNF protein affects the localization of and results in increased phosphorylation of and results in increased activity of RELA protein] mangiferin affects the localization of RELA protein mangiferin inhibits the reaction [Excitatory Amino Acid Agonists affects the localization of and results in increased activity of RELA protein]; mangiferin inhibits the reaction [Galactosamine results in increased expression of RELA protein] mangiferin results in decreased expression of RELA mRNA mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of RELA protein]; mangiferin inhibits the reaction [lead nitrate results in increased expression of RELA protein]; mangiferin inhibits the reaction [Scopolamine results in increased phosphorylation of and results in increased activity of RELA protein]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of RELA protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased localization of RELA protein] mangiferin results in decreased localization of RELA protein |
CTD |
PMID:15135318 PMID:15161907 PMID:19182383 PMID:19201465 PMID:20683903 PMID:21547680 PMID:22310181 PMID:23451106 PMID:26996543 PMID:27474068 More...
|
|
NCBI chr11:65,653,601...65,662,916
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RELB |
RELB proto-oncogene, NF-kB subunit |
decreases expression |
ISO |
mangiferin results in decreased expression of RELB mRNA |
CTD |
PMID:15135318 |
|
NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,449...45,038,198
|
|
G |
RIPK1 |
receptor interacting serine/threonine kinase 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of RIPK1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 6:3,063,967...3,115,187
Ensembl chr 6:3,063,824...3,115,187
|
|
G |
SAA1 |
serum amyloid A1 |
decreases expression |
ISO |
mangiferin results in decreased expression of SAA1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr11:18,266,264...18,269,967
Ensembl chr11:18,266,260...18,269,977
|
|
G |
SELE |
selectin E |
decreases expression |
ISO |
mangiferin results in decreased expression of SELE mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 1:169,722,640...169,734,079
Ensembl chr 1:169,722,640...169,764,705
|
|
G |
SELPLG |
selectin P ligand |
decreases expression |
ISO |
mangiferin results in decreased expression of SELPLG mRNA |
CTD |
PMID:15135318 |
|
NCBI chr12:108,621,895...108,633,894
Ensembl chr12:108,621,895...108,633,894
|
|
G |
SERPINE1 |
serpin family E member 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [AGT protein results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SLC22A1 |
solute carrier family 22 member 1 |
increases expression |
ISO |
mangiferin results in increased expression of SLC22A1 mRNA |
CTD |
PMID:21348301 |
|
NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,158,718
|
|
G |
SLC22A12 |
solute carrier family 22 member 12 |
decreases expression |
ISO |
mangiferin results in decreased expression of SLC22A12 mRNA; mangiferin results in decreased expression of SLC22A12 protein |
CTD |
PMID:21348301 |
|
NCBI chr11:64,591,220...64,602,344
Ensembl chr11:64,590,641...64,602,353
|
|
G |
SLC22A2 |
solute carrier family 22 member 2 |
increases expression |
ISO |
mangiferin results in increased expression of SLC22A2 mRNA |
CTD |
PMID:21348301 |
|
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
|
|
G |
SLC22A4 |
solute carrier family 22 member 4 |
increases expression |
ISO |
mangiferin results in increased expression of SLC22A4 mRNA |
CTD |
PMID:21348301 |
|
NCBI chr 5:132,294,394...132,344,190
Ensembl chr 5:132,294,394...132,344,190
|
|
G |
SLC22A5 |
solute carrier family 22 member 5 |
increases expression |
ISO |
mangiferin results in increased expression of SLC22A5 mRNA |
CTD |
PMID:21348301 |
|
NCBI chr 5:132,369,710...132,395,612
Ensembl chr 5:132,369,710...132,395,613
|
|
G |
SLC2A4 |
solute carrier family 2 member 4 |
multiple interactions increases expression |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose]]; mangiferin affects the localization of and results in increased activity of SLC2A4 protein; mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose]; mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Glucose] mangiferin inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 mRNA]; mangiferin inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 protein] mangiferin results in increased expression of SLC2A4 mRNA |
CTD |
PMID:19477051 PMID:29223569 |
|
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
|
|
G |
SNAI1 |
snail family transcriptional repressor 1 |
decreases expression |
EXP |
mangiferin results in decreased expression of SNAI1 protein |
CTD |
PMID:23707762 |
|
NCBI chr20:49,982,980...49,988,886
Ensembl chr20:49,982,980...49,988,886
|
|
G |
SNAI2 |
snail family transcriptional repressor 2 |
decreases expression |
EXP |
mangiferin results in decreased expression of SNAI2 protein |
CTD |
PMID:23707762 |
|
NCBI chr 8:48,917,598...48,921,429
Ensembl chr 8:48,917,598...48,921,740
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SOD1 mRNA] |
CTD |
PMID:17433543 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SRD5A2 |
steroid 5 alpha-reductase 2 |
decreases activity |
EXP |
mangiferin results in decreased activity of SRD5A2 protein |
CTD |
PMID:20823678 |
|
NCBI chr 2:31,522,480...31,663,009
Ensembl chr 2:31,522,480...31,580,938
|
|
G |
SRF |
serum response factor |
decreases expression |
ISO |
mangiferin results in decreased expression of SRF mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 6:43,171,269...43,181,506
Ensembl chr 6:43,171,269...43,181,506
|
|
G |
TAB1 |
TGF-beta activated kinase 1 (MAP3K7) binding protein 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of TAB1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr22:39,399,780...39,437,132
Ensembl chr22:39,399,778...39,437,060
|
|
G |
TBK1 |
TANK binding kinase 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of TBK1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr12:64,452,120...64,502,114
Ensembl chr12:64,452,090...64,502,114
|
|
G |
TERT |
telomerase reverse transcriptase |
decreases activity |
EXP |
mangiferin results in decreased activity of TERT protein |
CTD |
PMID:17634039 |
|
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO |
mangiferin promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TGFB1 mRNA] mangiferin inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of TGFB1 protein]; mangiferin inhibits the reaction [Streptozocin results in increased secretion of TGFB1 protein] |
CTD |
PMID:12694877 PMID:19706694 PMID:19960420 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TLR6 |
toll like receptor 6 |
decreases expression |
ISO |
mangiferin results in decreased expression of TLR6 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 4:38,822,897...38,868,390
Ensembl chr 4:38,822,897...38,856,817
|
|
G |
TLR7 |
toll like receptor 7 |
decreases expression |
ISO |
mangiferin results in decreased expression of TLR7 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr X:12,867,072...12,890,361
Ensembl chr X:12,867,072...12,890,361
|
|
G |
TLR8 |
toll like receptor 8 |
decreases expression |
ISO |
mangiferin results in decreased expression of TLR8 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr X:12,906,620...12,923,169
Ensembl chr X:12,906,620...12,923,169
|
|
G |
TLR9 |
toll like receptor 9 |
decreases expression |
ISO |
mangiferin results in decreased expression of TLR9 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions decreases expression affects expression increases secretion |
EXP ISO |
mangiferin inhibits the reaction [TNF protein affects the localization of and results in increased activity of NFKB1 protein]; mangiferin inhibits the reaction [TNF protein affects the localization of and results in increased phosphorylation of and results in increased activity of RELA protein]; mangiferin inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]; mangiferin inhibits the reaction [TNF protein results in increased degradation of NFKBIB protein]; mangiferin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of CXCR4 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of VEGFA mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of XIAP mRNA]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of IKBKB protein]; mangiferin inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein]; mangiferin inhibits the reaction [TNF protein results in increased secretion of IL6 protein] mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of NOS2 mRNA]; mangiferin inhibits the reaction [Galactosamine results in increased expression of TNF mRNA]; mangiferin inhibits the reaction [Galactosamine results in increased expression of TNF protein]; mangiferin inhibits the reaction [Isoproterenol results in increased expression of TNF protein] mangiferin results in decreased expression of TNF mRNA mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of TNF protein]; mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; mangiferin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; mangiferin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; mangiferin inhibits the reaction [Scopolamine results in increased expression of TNF protein]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of RELA protein] mangiferin affects the expression of TNF protein mangiferin results in increased secretion of TNF protein |
CTD |
PMID:12694877 PMID:15135318 PMID:15161907 PMID:15177305 PMID:15222974 PMID:19172585 PMID:19182383 PMID:20303935 PMID:21420233 PMID:21837981 PMID:22118634 PMID:22310181 PMID:27125760 PMID:27474068 More...
|
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF11A |
TNF receptor superfamily member 11a |
decreases expression |
ISO |
mangiferin results in decreased expression of TNFRSF11A mRNA |
CTD |
PMID:15135318 |
|
NCBI chr18:62,325,310...62,391,288
Ensembl chr18:62,325,287...62,391,288
|
|
G |
TNFSF11 |
TNF superfamily member 11 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNFSF11 protein results in increased degradation of NFKBIA protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ATP6V0D2 mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased localization of RELA protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:20683903 |
|
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Oxygen deficiency results in increased expression of TP53 protein] |
CTD |
PMID:10657591 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TRADD |
TNFRSF1A associated via death domain |
decreases expression |
ISO |
mangiferin results in decreased expression of TRADD mRNA |
CTD |
PMID:15135318 |
|
NCBI chr16:67,154,185...67,159,909
Ensembl chr16:67,154,185...67,159,909
|
|
G |
TRAF6 |
TNF receptor associated factor 6 |
decreases expression |
ISO |
mangiferin results in decreased expression of TRAF6 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr11:36,483,769...36,510,272
Ensembl chr11:36,483,769...36,510,272
|
|
G |
UCP1 |
uncoupling protein 1 |
multiple interactions |
ISO |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of UCP1 protein |
CTD |
PMID:32417366 |
|
NCBI chr 4:140,559,431...140,568,961
Ensembl chr 4:140,559,431...140,568,961
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
increases expression decreases activity |
EXP |
mangiferin results in increased expression of UGT1A1 mRNA mangiferin results in decreased activity of UGT1A1 protein |
CTD |
PMID:22815239 |
|
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|
G |
UGT1A9 |
UDP glucuronosyltransferase family 1 member A9 |
increases expression |
EXP |
mangiferin results in increased expression of UGT1A9 mRNA |
CTD |
PMID:22815239 |
|
NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300
|
|
G |
UGT2B7 |
UDP glucuronosyltransferase family 2 member B7 |
decreases activity |
EXP |
mangiferin results in decreased activity of UGT2B7 protein |
CTD |
PMID:22815239 |
|
NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987
|
|
G |
UMOD |
uromodulin |
affects expression |
ISO |
mangiferin affects the expression of UMOD protein |
CTD |
PMID:21348301 |
|
NCBI chr16:20,333,051...20,356,301
Ensembl chr16:20,333,051...20,356,301
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of VCAM1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions |
EXP |
mangiferin inhibits the reaction [TNF protein results in increased expression of VEGFA mRNA] |
CTD |
PMID:21420233 |
|
NCBI chr 6:43,770,209...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
VIM |
vimentin |
decreases expression multiple interactions |
EXP |
mangiferin results in decreased expression of VIM protein mangiferin affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of VIM protein] |
CTD |
PMID:23707762 PMID:32420661 |
|
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
|
|
G |
XIAP |
X-linked inhibitor of apoptosis |
multiple interactions decreases expression |
EXP |
mangiferin inhibits the reaction [TNF protein results in increased expression of XIAP mRNA] mangiferin results in decreased expression of XIAP protein |
CTD |
PMID:21420233 PMID:21547680 PMID:26996543 |
|
NCBI chr X:123,859,708...123,913,972
Ensembl chr X:123,859,724...123,913,976
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
increases expression |
EXP |
norathyriol results in increased expression of ABCB1 protein |
CTD |
PMID:20513373 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
affects binding decreases activity |
EXP ISO |
norathyriol binds to MAPK1 protein norathyriol results in decreased activity of MAPK1 protein |
CTD |
PMID:22084399 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
decreases activity |
ISO |
norathyriol results in decreased activity of MAPK3 protein |
CTD |
PMID:22084399 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
multiple interactions |
EXP |
norathyriol inhibits the reaction [GW 7647 results in increased activity of PPARA protein] |
CTD |
PMID:18393431 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARD |
peroxisome proliferator activated receptor delta |
multiple interactions |
EXP |
norathyriol inhibits the reaction [GW0742 results in increased activity of PPARD protein] |
CTD |
PMID:18393431 |
|
NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions |
EXP |
norathyriol inhibits the reaction [ciglitazone results in increased activity of PPARG protein] |
CTD |
PMID:18393431 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
|
G |
TSLP |
thymic stromal lymphopoietin |
multiple interactions |
ISO |
Phloxine O inhibits the reaction [calcipotriol increases expression of Tslp mRNA and protein in skin of external ear and phorbol 12-myristate 13-acetate increases expression of Tslp protein in keratinocytes] |
RGD |
PMID:29310423 |
RGD:38549374 |
NCBI chr 5:111,070,062...111,078,026
Ensembl chr 5:111,070,062...111,078,026
|
|
|
G |
SLC22A2 |
solute carrier family 22 member 2 |
multiple interactions |
EXP |
Propantheline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions |
EXP |
psorospermin inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin] |
CTD |
PMID:7083125 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions decreases uptake increases export |
EXP ISO |
3-methylquercetin inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 3-methylquercetin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; 5,7-dimethoxyflavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 5,7-dimethoxyflavone inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; 5-hydroxyflavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 5-methoxyflavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 5-oxo-hexahydroquinoline analog inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; abemaciclib inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; baicalein inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; baicalein promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; betulin inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; biochanin A inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; biochanin A promotes the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; CEP 33779 inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; daidzein inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; flavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; formononetin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Genistein promotes the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; glycitein promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; isovitexin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; kaempferol inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; myricetin inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; naringenin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; naringin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Quercetin inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; Quercetin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; quercitrin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Rutin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; tangeretin inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; tangeretin inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; taxifolin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123] [P-glycoprotein inducer and activator TX5 results in increased activity of ABCB1 protein] which results in increased export of Rhodamine 123; [Verapamil results in decreased activity of ABCB1 protein] inhibits the reaction [P-glycoprotein inducer and activator TX5 results in increased export of Rhodamine 123] |
CTD |
PMID:25058526 PMID:27816545 PMID:30391378 PMID:31756430 PMID:33321149 PMID:34217736 More...
|
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCG2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
increases export multiple interactions |
EXP |
ABCG2 protein results in increased export of Rhodamine 123 abemaciclib inhibits the reaction [ABCG2 protein results in increased export of Rhodamine 123] |
CTD |
PMID:27816545 |
|
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
|
|
|
G |
ACHE |
acetylcholinesterase (Cartwright blood group) |
decreases activity |
EXP |
rhodamine 6G results in decreased activity of ACHE protein |
CTD |
PMID:33844597 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
decreases activity |
EXP |
Rose Bengal results in decreased activity of ABCB1 protein |
CTD |
PMID:20041016 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
CYP19A1 |
cytochrome P450 family 19 subfamily A member 1 |
decreases activity |
ISO |
Rose Bengal results in decreased activity of CYP19A1 protein |
CTD |
PMID:18310892 |
|
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
decreases activity |
EXP |
Rose Bengal results in decreased activity of CYP3A4 protein |
CTD |
PMID:20041016 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
IYD |
iodotyrosine deiodinase |
decreases activity |
EXP |
Rose Bengal results in decreased activity of IYD protein |
CTD |
PMID:24012475 |
|
NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969
|
|
G |
KCNH2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
EXP |
Rose Bengal results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
|
|
G |
KLKB1 |
kallikrein B1 |
multiple interactions decreases response to substance |
ISO |
7-Ala-angiotensin (1-7) inhibits the reaction [KLKB1 gene mutant form results in decreased susceptibility to Rose Bengal]; nimesulide inhibits the reaction [KLKB1 gene mutant form results in decreased susceptibility to Rose Bengal]; splitomicin inhibits the reaction [KLKB1 gene mutant form results in decreased susceptibility to Rose Bengal] |
CTD |
PMID:25339356 |
|
NCBI chr 4:186,210,853...186,258,471
Ensembl chr 4:186,208,979...186,258,471
|
|
G |
UGT1A6 |
UDP glucuronosyltransferase family 1 member A6 |
decreases activity |
EXP |
Rose Bengal results in decreased activity of UGT1A6 protein |
CTD |
PMID:20041016 |
|
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
|
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 |
affects export affects transport |
EXP |
ABCC1 protein affects the export of vadimezan metabolite ABCC1 protein affects the transport of vadimezan analog |
CTD |
PMID:15282097 PMID:15784341 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
affects transport affects export |
EXP |
ABCC2 protein affects the transport of vadimezan analog ABCC2 protein affects the export of vadimezan metabolite |
CTD |
PMID:15282097 PMID:15784341 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
multiple interactions increases oxidation |
EXP |
Acridines analog inhibits the reaction [CYP1A2 protein results in increased oxidation of vadimezan] |
CTD |
PMID:16120190 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
IL1A |
interleukin 1 alpha |
increases expression |
ISO |
vadimezan results in increased expression of IL1A protein |
CTD |
PMID:16944150 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL6 |
interleukin 6 |
increases expression |
ISO |
vadimezan results in increased expression of IL6 protein |
CTD |
PMID:16944150 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
TNF protein affects the reaction [vadimezan affects the metabolism of Thalidomide] vadimezan results in increased expression of TNF protein |
CTD |
PMID:15060740 PMID:16944150 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
VEGFA |
vascular endothelial growth factor A |
increases expression |
ISO |
vadimezan results in increased expression of VEGFA protein |
CTD |
PMID:16944150 |
|
NCBI chr 6:43,770,209...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
decreases activity multiple interactions increases export increases transport |
EXP ISO |
Xanthenes results in decreased activity of ABCB1 protein closantel results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; Ivermectin results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; Rafoxanide results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; triclabendazole results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; triclabendazole sulfoxide results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; valspodar results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes] [valspodar results in decreased activity of ABCB1 protein] which results in decreased transport of Xanthenes ABCB1 protein results in increased export of Xanthenes ABCB1 protein results in increased transport of Xanthenes [valspodar results in decreased activity of ABCB1 protein] which results in decreased transport of Xanthenes; Calcium deficiency inhibits the reaction [ABCB1 protein results in increased export of Xanthenes] |
CTD |
PMID:18686201 PMID:20041016 PMID:20513441 PMID:21436125 PMID:25862123 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
AHR |
aryl hydrocarbon receptor |
multiple interactions |
ISO EXP |
Xanthenes binds to and results in increased activity of AHR protein |
CTD |
PMID:21431309 PMID:28186253 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
decreases activity |
EXP |
Xanthenes results in decreased activity of CYP3A4 protein |
CTD |
PMID:18686201 PMID:20041016 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
UGT1A6 |
UDP glucuronosyltransferase family 1 member A6 |
decreases activity |
EXP |
Xanthenes results in decreased activity of UGT1A6 protein |
CTD |
PMID:18686201 PMID:20041016 |
|
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
|
|
|
G |
ACE2 |
angiotensin converting enzyme 2 |
multiple interactions |
ISO |
xanthone inhibits the reaction [LEP protein results in increased activity of ACE2 protein]; xanthone inhibits the reaction [LEP protein results in increased expression of ACE2] |
CTD |
PMID:25205467 |
|
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
|
|
G |
LEP |
leptin |
multiple interactions |
ISO |
xanthone inhibits the reaction [LEP protein results in increased activity of ACE2 protein]; xanthone inhibits the reaction [LEP protein results in increased expression of ACE2] |
CTD |
PMID:25205467 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased expression of FOS protein] |
CTD |
PMID:21232528 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
IRAK1 |
interleukin 1 receptor associated kinase 1 |
multiple interactions |
ISO |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased ubiquitination of and results in increased degradation of IRAK1 protein] |
CTD |
PMID:21232528 |
|
NCBI chr X:154,010,507...154,019,902
Ensembl chr X:154,010,506...154,019,902
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased expression of JUN protein] |
CTD |
PMID:21232528 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:21232528 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:21232528 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] |
CTD |
PMID:21232528 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|